Dyne Therapeutics · 5 hours ago
Principal Scientist, ADME-PK
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The Principal Scientist, ADME-PK will utilize their expertise in drug metabolism and pharmacokinetics to advance the company's therapeutic efforts targeting muscle and CNS tissues.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Design and execute internal/external preclinical studies to understand the pharmacokinetics (PK) and absorption, metabolism, distribution, and excretion (ADME) of Dyne's drug candidates
Represent PCD as the ADME-PK subject matter expert on discovery and program teams
Partner with and support Research, Toxicology, Translational Biomarkers, Clinical, Regulatory, Project Management and other Dyne departments
Collaborate with Clinical Pharmacology/Pharmacometrics to develop quantitative tools to translate PK/PD relationship from preclinical to clinical
Author high quality Regulatory documents including INDs, CTAs, and NDA/BLA filings
Prepare strategic and science-based ADME strategies that meet regulatory requirements and program goals
Facilitate strategic scientific communication via meetings, abstracts and manuscripts
Qualification
Required
PhD in Pharmacokinetics, Pharmacology, Pharmaceutics, Biomedical Sciences or other relevant field with >6 years (MS with >8 years, BS with >12 years) of experience in the biopharmaceutical industry, with evidence of drug development experience
Strong knowledge of drug metabolism, ADME concepts, pharmacokinetics, pharmacodynamics and bioanalytical principles
Proficient in using WinNonlin or other pharmacokinetic software
Excellent communication (verbal and written) and presentation skills, as well as interpersonal skills and the ability to represent PCD in a team environment
Preferred
Familiarity with regulatory submission including FIH dosing strategy is highly desirable
Experience with PK characterization of protein therapeutics or antibody-drug conjugates (ADCs) is desired
Company
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
H1B Sponsorship
Dyne Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (4)
2024 (7)
2023 (1)
2022 (3)
2021 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.67BKey Investors
Hercules CapitalAtlas Venture
2025-12-09Post Ipo Equity· $402.5M
2025-06-30Post Ipo Equity· $230M
2025-06-30Post Ipo Debt· $100M
Recent News
2025-12-24
MarketScreener
2025-12-24
2025-12-24
Company data provided by crunchbase